Park National Corp’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,063
Closed -$542K 312
2020
Q1
$542K Sell
3,063
-437
-12% -$82.3K 0.03% 170
2019
Q4
$669K Buy
3,500
+34
+1% +$6.13K 0.03% 172
2019
Q3
$584K Hold
3,466
0.03% 181
2019
Q2
$580K Sell
3,466
-125
-3% -$17.3K 0.03% 187
2019
Q1
$526K Sell
3,591
-2,522
-41% -$366K 0.03% 190
2018
Q4
$817K Sell
6,113
-1,532
-20% -$251K 0.05% 159
2018
Q3
$1.46M Sell
7,645
-1,196
-14% -$220K 0.08% 126
2018
Q2
$1.47M Sell
8,841
-8,155
-48% -$1.31M 0.08% 116
2018
Q1
$2.86M Sell
16,996
-32,273
-66% -$5.41M 0.17% 83
2017
Q4
$8.06M Buy
49,269
+10,459
+27% +$1.88M 0.45% 54
2017
Q3
$7.95M Buy
38,810
+4,011
+12% +$933K 0.46% 53
2017
Q2
$8.46M Buy
34,799
+1,837
+6% +$432K 0.5% 48
2017
Q1
$7.88M Buy
32,962
+1,925
+6% +$448K 0.47% 50
2016
Q4
$6.52M Buy
31,037
+18,822
+154% +$3.9M 0.4% 55
2016
Q3
$2.81M Buy
12,215
+2,541
+26% +$621K 0.18% 79
2016
Q2
$2.23M Buy
9,674
+5,329
+123% +$1.23M 0.14% 95
2016
Q1
$1.17M Buy
+4,345
New +$1.24M 0.08% 128

Other funds holding AGN

Park National Corp's AGN Position: Q2 2020 in Review

Park National Corp sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,063 shares — an estimated $542K sold.

Park National Corp first reported a position in AGN in Q1 2016 and held it in 17 quarters. The position peaked at $8.46M in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Park National Corp reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Park National Corp sold 3,063 Allergan plc shares in Q2 2020, an estimated $542K.
  • Park National Corp first reported a position in Allergan plc in Q1 2016 and held it in 17 quarters.
  • Park National Corp's Allergan plc position peaked at $8.46M in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Park National Corp's 13F filing for Q2 2020, filed 1 Jul 2020.